ideas by gul ahmed

While adaptive biotechnologies shareholders are down 28% for the year, the market itself is up 33%. Adpt) is owned by 82.67% institutional shareholders, 59.01% adaptive biotechnologies corp insiders, and 0.00% retail investors. …